Home
About
Overview
Sharing Data
ORCID
Help
History (82)
Light and electron microscopic analysis of enkephalin-like immunoreactivity in the basolateral amygdala, including evidence for convergence of enkephalin-containing axon terminals and norepinephrine transporter-containing axon terminals onto common targets.
Pharyngeal and upper esophageal sphincter manometry in humans.
Hydrogen Isotope Fractionation during the Biodegradation of 1,2-Dichloroethane: Potential for Pathway Identification Using a Multi-element (C, Cl, and H) Isotope Approach.
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.
Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study.
See All 82 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study.
Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study. Aust Health Rev. 2009 May; 33(2):325-33.
View in:
PubMed
subject areas
Adult
Australia
Cardiovascular Diseases
Cholesterol
Cost-Benefit Analysis
Cross-Sectional Studies
Eligibility Determination
Female
Humans
Hypercholesterolemia
Hypolipidemic Agents
Insurance Benefits
Insurance, Pharmaceutical Services
Male
Middle Aged
Risk Factors
Triglycerides
authors with profiles
Robert J. Adams